Bill Haney, Skyhawk CEO (Dave Pedley/Getty Images for SXSW)
Bill Haney adds another $133M to Skyhawk's coffers, as the RNA startup guns for the clinic
A few years after becoming one of the first major biotechs out to drug RNA with small molecules, serial entrepreneur and filmmaker Bill Haney is …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
